Skip to main content

Mireia del Toro Riera

I am a pediatrician, specialist in Pediatric Neurology and Coordinator of the Metabolic Unit. My activity focuses mainly on metabolic diseases, working to improve the diagnosis, treatment and quality of life of patients and their families. We participate in research in these group of diseases through different projects and clinical trials of advanced therapies. Since 2020 I coordinate the hospital's Rare Diseases program and its Commission. I also coordinate or participate in different external committees in the same field.

Institutions of which they are part

Pediatric Neurology
Vall Hebron Institut de Recerca
Doctor
Paediatric Neurology
Children's Hospital and Woman's Hospital
Medical Coordinator
Rare diseases
Cross-departmental services

Mireia del Toro Riera

Institutions of which they are part

Pediatric Neurology
Vall Hebron Institut de Recerca
Doctor
Paediatric Neurology
Children's Hospital and Woman's Hospital
Medical Coordinator
Rare diseases
Cross-departmental services

I am a pediatrician, specialist in Pediatric Neurology and Coordinator of the Metabolic Unit. My activity focuses mainly on metabolic diseases, working to improve the diagnosis, treatment and quality of life of patients and their families. We participate in research in these group of diseases through different projects and clinical trials of advanced therapies. Since 2020 I coordinate the hospital's Rare Diseases program and its Commission. I also coordinate or participate in different external committees in the same field.

I studied Medicine at the Autonomous University of Barcelona and did my Pediatrics residency at Vall d'Hebron University Hospital (1990-1994). It followed a specialization in Pediatric Neurology at the same hospital where I am consultant doctor since 1999.
In 2004 I began my specific dedication to metabolic diseases coordinating the unit that in 2012 was consolidated as a Spanish reference unit (CSUR) and later in Europe (ERN) and Catalonia (XUEC) and participates in the Neonatal Screening program of Catalonia. I currently coordinate the group of lysosomal diseases both in Metab-ERN and in AECOM (Spanish Association of Metabolic Diseases).
I participate in various research projects both collaborating with basic research groups and with registries and clinical trials of advanced therapies in metabolic diseases within the VHIR Pediatric Neurology research group.
Since 2020 I coordinate the hospital's rare diseases program and its commission. Our center is the public hospital that cares for the largest number of patients with these diseases in Catalonia and it is a challenge to work together to improve the experience and quality of life of patients and their environment as well as to maintain the level of expertise they deserve. In the same area I coordinate the PADEICS of rare diseases and participate in the Advisory Commission of the Department of Health.

Projects

Bases genéticas de la malformación de Chiari tipo I

IP: Alfons Macaya Ruíz
Collaborators: Susana Boronat Guerero, Mireia del Toro Riera, Daniel Carranza Rojo
Funding agency: Instituto de Salud Carlos III
Funding: 84216
Reference: PI061606
Duration: 01/01/2007 - 30/09/2010

Papel del TGFß en la progresión de la distrofia muscular de Duchenne

IP: -
Collaborators: Mireia del Toro Riera, Mario Marotta Baleriola
Funding agency: Instituto de Salud Carlos III
Funding: 98010
Reference: PI061164
Duration: 01/01/2007 - 30/06/2010

Identificación y caracterización molecular de factores modificadores de la necrosis o de la regeneración muscular en el ratón mdx.

IP: -
Collaborators: José Antonio Arranz Amo, María Angeles Artaza Marino, Mireia del Toro Riera, Mario Marotta Baleriola
Funding agency: Instituto de Salud Carlos III
Funding: 91425
Reference: PI030106
Duration: 01/01/2003 - 28/11/2006

Evaluación de genes de susceptibilidad a migraña mediante estudios de asociación a variantes polimórficas tipo SNP y análisis de ligamento genético en sujetos y familias con migraña.

IP: Alfons Macaya Ruíz
Collaborators: Mireia del Toro Riera
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 92000
Reference: SAF2003-04704
Duration: 15/12/2003 - 14/12/2006

Ministerio de Ciencia

Related news

The ClinPrior algorithm achieved a positive diagnosis rate of 70% in two minority diseases of neurodegenerative origin, which represents double the number of cases that are diagnosed with current tools.

Over the course of two days, experts presented the latest advances in vectors, different gene modification techniques and their transfer to clinical practice.

El 20% dels pacients en els quals s’havia trobat alguna predisposició genètica van ser diagnosticats amb algun tipus de tumor i van poder iniciar el tractament de manera precoç.

Related professionals

Deborah Pareto Onghena

Deborah Pareto Onghena

Main researcher
Neuroradiology
Read more
Mª Dolores Braquehais Conesa

Mª Dolores Braquehais Conesa

Main researcher
Psychiatry, Mental Health and Addictions
Read more
Lucas Rivera Sánchez

Lucas Rivera Sánchez

Read more
Clara Carnicer Cáceres

Clara Carnicer Cáceres

Postdoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.